[go: up one dir, main page]

HK1210011B - N-{[(7s)-3，4-二甲氧二环[4．2．0]辛-1，3，5-三烯-7-基]甲基}-3-(7，8-二甲氧基-1，2，4，5-四氢-3h-3-苯并氮杂䓬-3-基)-n-甲基-3-氧代-1-丙胺和培哚普利的组合 - Google Patents

N-{[(7s)-3，4-二甲氧二环[4．2．0]辛-1，3，5-三烯-7-基]甲基}-3-(7，8-二甲氧基-1，2，4，5-四氢-3h-3-苯并氮杂䓬-3-基)-n-甲基-3-氧代-1-丙胺和培哚普利的组合 Download PDF

Info

Publication number
HK1210011B
HK1210011B HK15110660.1A HK15110660A HK1210011B HK 1210011 B HK1210011 B HK 1210011B HK 15110660 A HK15110660 A HK 15110660A HK 1210011 B HK1210011 B HK 1210011B
Authority
HK
Hong Kong
Prior art keywords
methyl
perindopril
dimethoxybicyclo
octa
dimethoxy
Prior art date
Application number
HK15110660.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1210011A1 (zh
Inventor
Christian Thuillez
Paulus Mulder
Jean-Paul Vilaine
Marie-Dominique Fratacci
Guy Lerebours-Pigeonniere
Luc Feldmann
Jérôme Roussel
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1002525A external-priority patent/FR2961105B1/fr
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HK1210011A1 publication Critical patent/HK1210011A1/zh
Publication of HK1210011B publication Critical patent/HK1210011B/zh

Links

HK15110660.1A 2010-06-15 2015-10-28 N-{[(7s)-3，4-二甲氧二环[4．2．0]辛-1，3，5-三烯-7-基]甲基}-3-(7，8-二甲氧基-1，2，4，5-四氢-3h-3-苯并氮杂䓬-3-基)-n-甲基-3-氧代-1-丙胺和培哚普利的组合 HK1210011B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1002525 2010-06-15
FR1002525A FR2961105B1 (fr) 2010-06-15 2010-06-15 Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque

Publications (2)

Publication Number Publication Date
HK1210011A1 HK1210011A1 (zh) 2016-04-15
HK1210011B true HK1210011B (zh) 2017-02-17

Family

ID=

Similar Documents

Publication Publication Date Title
MXPA06012116A (es) Uso de flibanserina en el tratamiento del trastornos premestruales y otros trastornos sexuales femeninos.
DK2921168T3 (en) Combination of N - {[(7S) -3,4-dimethoxybicyclo [4.2.0] octa-1,3,5-trien-7-yl] methyl} -3- (7,8-dimethoxy-1,2, 4,5-Tetrahydro-3H-3-benzazepin-3-yl) -n-methyl-3-oxo-1-propanamine and perindopril
EP2832357A1 (en) Selective AT2 receptor agonists for use in treatment of cachexia
US20120196850A1 (en) ASSOCIATION OF A SINUS NODE If CURRENT INHIBITOR AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
US11931341B2 (en) Compositions and methods for the treatment and prevention of muscular dystrophy
HK1210011B (zh) N-{[(7s)-3，4-二甲氧二环[4．2．0]辛-1，3，5-三烯-7-基]甲基}-3-(7，8-二甲氧基-1，2，4，5-四氢-3h-3-苯并氮杂䓬-3-基)-n-甲基-3-氧代-1-丙胺和培哚普利的组合
KR101078133B1 (ko) 동방 결절 ｉｆ 흐름 억제제와 베타 차단제의 회합체
EP4424309A1 (en) Composite composition containing angiotensin receptor blocker and sglt2 inhibitor
HU201244B (en) Process for production of medical compositions containing as active substance derivatives of quinoline applicable for treatment of heart-arithmia
JPH10139664A (ja) 抗不整脈薬
HK1165283A (zh) 窦房结if当前抑制剂和血管紧张素转化酶抑制剂的组合在治疗心力衰竭中的用途
OA16276A (fr) Utilisation de l'association d'un inhibiteur du courant IF sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque.